Annexin Pharmaceuticals AB (SE0025159387) — research page
SE · se-cm-kg/SSME/SE0025159387 · as of 2026-11-06
Identity and listing
The issuer is Annexin Pharmaceuticals AB, listed on First North Sweden under ticker SE0025159387, ISIN SE0025159387 and LEI 5493000JP703HGPJEX27. Its security type, segment, sector and jurisdiction are not on the record. Its listing status is listed, not halted.
| field | value | source · read date |
|---|---|---|
| name | Annexin Pharmaceuticals AB | source · 2026-11-06 |
| exchange | First North Sweden | source · 2026-11-06 |
| ticker | SE0025159387 | source · 2026-11-06 |
| ISIN | SE0025159387 | source · 2026-11-06 |
| LEI | 5493000JP703HGPJEX27 | source · 2026-11-09 |
| security type | not on the record | |
| segment | not on the record | |
| sector | not on the record | |
| jurisdiction | not on the record | |
| status | listed, not halted | source · 2026-11-09 |
The disclosure read
The record holds 28 filings on 26 filing days in the window 2025-11-06 to 2026-11-06. The median gap between filing days is 9 days, against a median of 11.0 days for First North Sweden, which holds 325 issuers. Latency from the latest filing to the record date 2026-11-06 is 15 days, against a median of 7 days for the exchange. The sector median is not on the record. The latest filing is an Investor News item dated 2026-10-22.
| filings | median gap between filing days | days from latest filing to as-of | |
|---|---|---|---|
| this issuer | 28 | 9 | 15 |
| exchange median: First North Sweden (325 issuers) | 21 | 11 | 7 |
| date | type | category | filing |
|---|---|---|---|
| 2026-10-22 | Investor News | Investor News | Annexin completes patient enrolment in the NEXUS study - multiple key clinical and regulatory milestones ahead |
| 2026-10-22 | Interim report (Q1 and Q3) | Interim report (Q1 and Q3) | Annexin Pharmaceuticals delårsrapport januari - september 2026 |
| 2026-10-16 | Investor News | Investor News | Inbjudan till presentation av Annexins delårsrapport för tredje kvartalet 2026 |
| 2026-09-17 | Investor News | Investor News | First patient treated with vanexin following anti-VEGF injection in the NEXUS study |
| 2026-08-21 | Half year financial report | Half year financial report | Annexin Pharmaceuticals halvårsrapport januari - juni 2026 |
window 2025-11-06 to 2026-11-06 · the node's disclosure lines, as get_filings serves them
Auditor
The auditor of record is not on the record, nor is its location. The market's record does not carry auditor changes.
Events and halts
The record carries no listing, delisting, name change, domicile change or segment move lines, because the lifecycle type map for this register is not yet in place. The issuer is listed and not halted.
Orderability
The outcome is not determinable under acm-68000/se/mifid-ii-product-governance/r1, as of 2026-11-04. The chapter's orderability section carries no client categories, so the outcome cannot name its client category.
rule acm-68000/se/mifid-ii-product-governance/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability
Coverage
No research houses were found on the investor-relations pages read.
Open research
No openly published research notes were found on the record.
Licensed
Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.
| licensor | entitlement | title | date | source |
|---|---|---|---|---|
| none loaded |
As-of depth
The vintage for this market is not sealed. No issuer years are sealed, and the market's earliest sealed date and the live record start date are not on the record.
Sources
6 source pages are named on this page; every value above carries its own source page and read date in the numbers.
- 10.1
- https://firds.esma.europa.eu/firds/ (identity.exchange)
- 10.2
- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)
- 10.3
- https://mcp.se-cm-kg.ai/events/SSME/SE0025159387 (the disclosure lines)
- 10.4
- https://api.news.eu.nasdaq.com/news/query.action?globalGroup=exchangeNotice&globalName=ExchangenewsFilter|FirstNorthInformation (the halt flag)
- 10.5
- https://se.eu-cm-kg.ai/book/aio.json (the orderability chapter)
- 10.6
- https://mcp.se-cm-kg.ai/record/SSME/SE0025159387 (the record)
Read it by agent
The same page, signed and receipted: get_research at https://mcp.getresearch.ai/mcp with {"isin":"SE0025159387"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:daee8f1dd8f679ac.